• Loading stock data…

Oxurion Receives Transparency Notifications Based on New Denominator

Last Updated on November 17, 2022 by GlobeNewsWire

Leuven, BELGIUM, Boston, MA, US November 17, 2022 – 8 AM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows:

Following the issuance of new shares pursuant to the Capital Commitment entered into with Negma Group Ltd., the updated denominator for transparency notifications was 109,075,765 shares as of November 11, 2022: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA

Print Friendly, PDF & Email
Spread the word

Reader Interactions

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Generated by Feedzy